Synthetic biology uses engineering principles to improve natural products by combining rational design with our knowledge of how individual cells, animal organs and plants live. It offers exciting opportunities for new products to transform agricultural, food, healthcare and manufacturing industries. The cutting-edge discipline of synthetic biology has recently been named by UK Government as one of “Eight Great Technologies” that support UK science strengths and business capabilities and in which Britain could be a world leader.
- Home
- About us
-
Portfolio
- Medical/ Biotechnology
- Environmental Technologies
- ICT
- Software
- Services
- Exits
- Other
- RSF People
- The Fund Manager
- FAQs
- News & Blog
- Contact
Blog
Genome editing techniques: The science and the ethics Synthetic biology brings hope for Chlamydia vaccine Taking experiments from lab to market – thoughts from SynBioBeta London Read more-
Register
-
Latest Tweets
Mobile App Accelerator Neumob Raises $8.5M Series A Led By Accel Partners ow.ly/T0QXc
About 14 minutes ago from RainbowSeedFund's Twitter via Hootsuite
Looking for #investment in your #tech company? Take a look at our website: goo.gl/8Ub9xc
About 55 minutes ago from RainbowSeedFund's Twitter via Hootsuite
Impact Is The New Mobile ow.ly/T0QWY
About 3 hours ago from RainbowSeedFund's Twitter via Hootsuite
UK government works with #NASA to track drones goo.gl/RbixaX
About 3 days ago from RainbowSeedFund's Twitter via Hootsuite
thank you to all the staff and portfolio companies that came to our offices yesterday to enjoy cofee and cakes in support of macmillan
About 3 days ago from RainbowSeedFund's Twitter via Hootsuite
-
STAY IN TOUCH
Office +44(0)121 710 1990
Email:
Follow @RainbowSeedFund
-
Copyright Info
© Rainbow Seed Fund 2015. All Rights Reserved. Midven Limited is authorised and regulated by the Financial conduct authority FRN 148549. Company Registration No.: 2500898 Registered Address: Cavendish House 39 - Birmingham ,
Website by MJ Design
